Terms: = Brain cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Clinical Outcome
4 results:
1. clinical outcome and evidence of high rate post-surgical anterior hypopituitarism in a cohort of TSH-secreting adenoma patients: Might somatostatin analogs have a role as first-line therapy?
Gatto F; Grasso LF; Nazzari E; Cuny T; Anania P; Di Somma C; Colao A; Zona G; Weryha G; Pivonello R; Ferone D
Pituitary; 2015 Oct; 18(5):583-91. PubMed ID: 25326851
[TBL] [Abstract] [Full Text] [Related]
2. [Autoimmune encephalitis, clinical, radiological and immunological data].
Aupy J; Collongues N; Blanc F; Tranchant C; Hirsch E; De Seze J
Rev Neurol (Paris); 2013 Feb; 169(2):142-53. PubMed ID: 23099105
[TBL] [Abstract] [Full Text] [Related]
3. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lee SM; Khan I; Upadhyay S; Lewanski C; Falk S; Skailes G; Marshall E; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Chao D; Middleton G; Bulley S; Ngai Y; Rudd R; Hackshaw A; Boshoff C
Lancet Oncol; 2012 Nov; 13(11):1161-70. PubMed ID: 23078958
[TBL] [Abstract] [Full Text] [Related]
4. Toxicity, efficacy, and pharmacology of suramin in adults with recurrent high-grade gliomas.
Grossman SA; Phuphanich S; Lesser G; Rozental J; Grochow LB; Fisher J; Piantadosi S;
J Clin Oncol; 2001 Jul; 19(13):3260-6. PubMed ID: 11432894
[TBL] [Abstract] [Full Text] [Related]
